Aktie A14WFY BG MEDICINE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen BG Medicine, Inc.

Aktien

A14WFY

US08861T2069

BGMD

Markt geschlossen - OTC Markets
Andere Börsenplätze
 16:36:41 06.12.2023 		% 5 Tage % 1. Jan.
0,000001 USD -.--% Intraday Chart für BG Medicine, Inc. -.--% -.--%
2015 Transcript : BG Medicine, Inc. - Special Call
2015 Transcript : BG Medicine, Inc., Q2 2015 Earnings Call, Aug 19, 2015

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015
BG Medicine Announces Board Changes
BG Medicine Withdraws 510(K) Premarket Notification for Proposed Additional Indication for the Bgm Galectin-3® Test
BG Medicine, Inc. Amends License and Distribution Agreement for Galectin-3 with Abbott Laboratories
BG Medicine, Inc. Announces Board Changes
BG Medicine, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015
Certain Options of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015.
Certain Warrants of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015.
Certain shares of BG Medicine, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 11-NOV-2015.
Timothy Harris Resigns to Board of Directors and Audit Committee of BG Medicine, Inc
BG Medicine, Inc.(OTCPK:BGMD) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index
BG Medicine, Inc.(OTCPK:BGMD) dropped from S&P TMI Index
BG Medicine, Inc.(OTCPK:BGMD) dropped from CRSP US Total Market Index
BG Medicine, Inc.(NasdaqCM:BGMD) dropped from NASDAQ Composite Index
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015
BG Medicine, Inc. Announces Payoff of Secured Term Loan
BG Medicine, Inc. announced that it has received $2.5 million in funding from Flagship Ventures.
BG Medicine, Inc. Announces First Automated Test for Galectin-3 Now Available in U.S
BGMD Seeks Acquisitions
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Financial Guidance for 2015
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14WFY Aktie
  4. Nachrichten BG Medicine, Inc.
  5. Andere Sprachen